Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay

Anti-Cancer Drugs

Volumn 7, Issue 5, 1996, Pages 568-578

  Tiberghien, Françoise ^a   Loor, Francis ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

calcein AM; multidrug resistance; P glycoprotein; SDZ PSC 833

Indexed keywords

ACETOXYMETHYL CALCEIN; AMIODARONE; BETA LUMICOLCHICINE; CHLOROQUINE; COLCHICINE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MEPACRINE; QUINIDINE; SDZ 280446; SUBSTRATE; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; ARTICLE; ASSAY; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029793039     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199607000-00012     Document Type: Article

References (27)

1. Gupta S, Tsuruo T. Multidrug resistance in cancer cells: cellular, biochemical, molecular and biological aspects. New York: Wiley & Sons 1996.
2. Boesch D, Gavériaux C, Loor F. Reversal of multidrug-resistance in CHO cells by Cyclosporin A and other resistance modifying agents. J Cell Pharmacol 1991; 2: 92-8.
3. Gavériaux C, Boesch D, Jachez B, Bollinger P, Payne T, Loor F. SDZ PSC 833, a non-immunosuppressive cyclosporin analog, is a very potent multidrug-resistance modifier. J Cell Pharmacol 1991; 2: 225-34.
4. Inaba M, Nagashima K, Sakurai Y, Fukui M, Yanagai Y. Reversal of multidrug resistance by non-antitumor anthracycline analogs. Jpn J Cancer Res (Gann) 1984; 75: 1049-52.
5. Inaba M, Nagashima K. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro. Jpn J Cancer Res (Gann) 1986; 77: 197-204.
6. Jackson DV, Long TR, Trahey TF, Morgan TM. Synergistic antitumor activity of vincristine and VP-16-213 Cancer Chemother Pharmacol 1984; 13: 176-80.
7. Yalowich JC. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro. Cancer Res 1987; 47: 1010-5.
8. Beck WT, Cirtain MC, Look AT, Ashmun TA. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Biochem Biophys Res Commun 1988; 153: 959-66.
9. Ford JM, Hait WN, Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990; 42: 155-99.
10. Boesch D, Muller K, Pourtier-Manzanedo A, Loor F. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. Exp Cell Res 1991; 196: 26-32.
11. Pourtier-Manzanedo A, Didier AD, Muller CD, Loor F. SDZ PSC 833 and SDZ 280-446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells. Anti-Cancer Drugs 1992; 3: 419-25.
12. Boesch D, Loor F. Extent and persistance of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents. Anti-Cancer Drugs 1994; 5: 229-38.
13. Lee J-S, Paull K, Alvarez M, et al. Rhodamine efflux pattern predict P-glycoprotein substrates in the National Cancer Institute Drug Screen. Mol Pharmacol 1994; 46: 627-38.
14. Didier A, Wenger J, Loor F. Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemia cells and restoration of normal retention by Pgp blockers. Anti-Cancer Drugs 1995; 6: 669-80.
15. Homolya L, Hollo Zs, Germann UA, Pastan I, Gottesman MM, Sarkadi B. Fluorescent cellular indicators are extruded by the the multidrug-resistance protein. J Biol Chem 1993; 268: 21493-6.
16. Hollo Zs, Homolya L, Davis CW, Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1994; 1191: 384-8.
17. Liminga G, Nygren P, Larsson R. Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833. Exp Cell Res 1994; 212: 291-6.
18. Didier A, Tiberghien F, Wenger R, Loor F. Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin A. Anti-Cancer Drugs 1996; 7: 257-65.
19. Loor F, Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Emmer G. SDZ 280-446, a novel semi-synthetic cyclopeptolide:in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug-resistance. Br J Cancer 1992; 65: 11-8.
20. Jachez B, Nordmann R, Loor F. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporin SDZ PSC 833 und the cyclopeptolide SDZ 280-446. J Natl Cancer Inst 1993; 85: 478-83.
21. Chauffert B, Martin M, Hamman A, Michel MF, Martin F. Amiodarone-induced enhancement of doxorubicin and 4′-deoxyrubicin cytotoxicity to rat colon cancer cells in vitro and in vivo. Cancer Res 1986; 46: 825-30.
22. Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Yakurai Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adryamicin in drug-resistant tumor cells. Cancer Res 1984; 44: 4303-7.
23. Ramu A, Spanier R, Rahaminoff H, Fuks Z. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukemia cells. Br J Cancer 1984; 50: 501-7.
24. Shiraishi N, Akiyama S, Kobayashi M, Kuwano M. Lysosomotropic agents reverse multiple drug resistance in human cancer cells. Cancer Lett 1986; 30: 251-9.
25. Zamora JM, Beck WT. Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells. Biochem Pharmacol 1986; 35: 4303-10.
26. Inaba M, Maruyama E. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine. Cancer Res 1988; 48: 2064-7.
27. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1988; 33: 454-62.